Effect of granulocyte colony–stimulating factor administration on renal regeneration after experimentally induced acute kidney injury in dogs

Chae-Young Lim Department of Veterinary Internal Medicine, College of Veterinary Medicine, Konkuk University, Seoul 143-701, South Korea.

Search for other papers by Chae-Young Lim in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Jae-Ik Han Department of Veterinary Internal Medicine, College of Veterinary Medicine, Konkuk University, Seoul 143-701, South Korea.

Search for other papers by Jae-Ik Han in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Seung-Gon Kim Department of Veterinary Internal Medicine, College of Veterinary Medicine, Konkuk University, Seoul 143-701, South Korea.

Search for other papers by Seung-Gon Kim in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Chang-Min Lee Department of Veterinary Internal Medicine, College of Veterinary Medicine, Konkuk University, Seoul 143-701, South Korea.

Search for other papers by Chang-Min Lee in
Current site
Google Scholar
PubMed
Close
 DVM
, and
Hee-Myung Park Department of Veterinary Internal Medicine, College of Veterinary Medicine, Konkuk University, Seoul 143-701, South Korea.

Search for other papers by Hee-Myung Park in
Current site
Google Scholar
PubMed
Close
 DVM, PhD

Abstract

OBJECTIVE To evaluate the effects of granulocyte colony–stimulating factor (GCSF) administration in dogs with experimentally induced acute kidney injury.

ANIMALS 6 healthy dogs.

PROCEDURES After induction of kidney injury (day 0) with cisplatin (5 mg/kg, IV), the dogs were randomly assigned into 2 groups (n = 3 dogs/group). Then dogs immediately received GCSF (10 μg/kg) or 1 mL of saline (0.9% NaCl) solution (control group) SC; this treatment was repeated once daily for 4 additional days (days 1 through 4). A once-daily CBC (day 0 to 4), serum biochemical analysis (day 0 to 3), and urinalysis (day 0 to 3) were performed for each dog; samples were collected before administration of cisplatin (day 0) and before treatment with GCSF or saline solution (days 1 through 4). After sample collection and treatment on day 4, all dogs were euthanized; kidney tissue samples underwent histologic evaluation, immunohistochemical analyses, and cytokine profiling via reverse transcriptase PCR assay.

RESULTS In the GCSF-treated group, the histologic evaluation and immunohistochemical analyses of kidney tissue revealed less fibrotic change and greater proliferation of renal tubular epithelial cells, compared with findings in the control group. The mRNA profiles of kidney tissue from the GCSF-treated group indicated lower expression of tumor necrosis factor-α and tumor growth factor-β, compared with findings in the control group; however, concentrations of factors related to renal regeneration were not greater in the GCSF-treated group.

CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that GCSF treatment can impede renal fibrosis and increase proliferation of renal tubules after experimentally induced acute kidney injury in dogs. (Am J Vet Res 2016;77:199–207)

Abstract

OBJECTIVE To evaluate the effects of granulocyte colony–stimulating factor (GCSF) administration in dogs with experimentally induced acute kidney injury.

ANIMALS 6 healthy dogs.

PROCEDURES After induction of kidney injury (day 0) with cisplatin (5 mg/kg, IV), the dogs were randomly assigned into 2 groups (n = 3 dogs/group). Then dogs immediately received GCSF (10 μg/kg) or 1 mL of saline (0.9% NaCl) solution (control group) SC; this treatment was repeated once daily for 4 additional days (days 1 through 4). A once-daily CBC (day 0 to 4), serum biochemical analysis (day 0 to 3), and urinalysis (day 0 to 3) were performed for each dog; samples were collected before administration of cisplatin (day 0) and before treatment with GCSF or saline solution (days 1 through 4). After sample collection and treatment on day 4, all dogs were euthanized; kidney tissue samples underwent histologic evaluation, immunohistochemical analyses, and cytokine profiling via reverse transcriptase PCR assay.

RESULTS In the GCSF-treated group, the histologic evaluation and immunohistochemical analyses of kidney tissue revealed less fibrotic change and greater proliferation of renal tubular epithelial cells, compared with findings in the control group. The mRNA profiles of kidney tissue from the GCSF-treated group indicated lower expression of tumor necrosis factor-α and tumor growth factor-β, compared with findings in the control group; however, concentrations of factors related to renal regeneration were not greater in the GCSF-treated group.

CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that GCSF treatment can impede renal fibrosis and increase proliferation of renal tubules after experimentally induced acute kidney injury in dogs. (Am J Vet Res 2016;77:199–207)

  • 1. Star RA. Treatment of acute renal failure. Kidney Int 1998; 54: 18171831.

  • 2. Ross L. Acute kidney injury in dogs and cats. Vet Clin North Am Small Anim Pract 2011; 41: 114.

  • 3. Cowgill LD, Francey T. Acute uremia. In: Ettinger SJ, Feldman EC, eds. Textbook of veterinary internal medicine. 3rd ed. St Louis: Saunders Elsevier, 2005;17311751.

    • Search Google Scholar
    • Export Citation
  • 4. Ali BH, Al Moundhri MS. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Food Chem Toxicol 2006; 44: 11731183.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5. Knapp DW, Richardson RC, Bonney PL, et al. Cisplatin therapy in 41 dogs with malignant tumors. J Vet Intern Med 1988; 2: 4146.

  • 6. Berg J. Canine osteosarcoma: amputation and chemotherapy. Vet Clin North Am Small Anim Pract 1996; 26: 111121.

  • 7. Chun R, Knapp DW, Widmer WR, et al. Cisplatin treatment of transitional cell carcinoma of the urinary bladder in dogs: 18 cases (1983–1993). J Am Vet Med Assoc 1996; 209: 15881591.

    • Search Google Scholar
    • Export Citation
  • 8. Barabas K, Milner R, Lurie D, et al. Cisplatin: a review of toxicities and therapeutic applications. Vet Comp Oncol 2008; 6: 118.

  • 9. Caglar K, Kinalp C, Arpaci F, et al. Cumulative prior dose of cisplatin as a cause of the nephrotoxicity of high-dose chemotherapy followed by autologous stem-cell transplantation. Nephrol Dial Transplant 2002; 17: 19311935.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10. Daugaard G, Abildgaard U, Holstein-Rathlou NH, et al. Acute effect of cisplatin on renal hemodynamics and tubular function in dog kidneys. Ren Physiol 1986; 9: 308316.

    • Search Google Scholar
    • Export Citation
  • 11. Daugaard G, Abildgaard U, Holstein-Rathlou NH, et al. Effect of cisplatin on renal haemodynamics and tubular function in the dog kidney. Int J Androl 1987; 10: 347351.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12. Daugaard G, Abildgaard U, Larsen S, et al. Functional and histopathological changes in dog kidneys after administration of cisplatin. Ren Physiol 1987; 10: 5464.

    • Search Google Scholar
    • Export Citation
  • 13. Rewerts JM, McCaw DL, Cohn LA, et al. Recombinant human granulocyte colony-stimulating factor for treatment of puppies with neutropenia secondary to canine parvovirus infection. J Am Vet Med Assoc 1998; 213: 991992.

    • Search Google Scholar
    • Export Citation
  • 14. Mischke R, Barth T, Wohlsein P, et al. Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on leukocyte count and survival rate of dogs with parvoviral enteritis. Res Vet Sci 2001; 70: 221225.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15. Crawford J. Safety and efficacy of pegfilgrastim in patients receiving myelosuppressive chemotherapy. Pharmacotherapy 2003; 23: 15S19S.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16. Eyles JL, Roberts AW, Metcalf D, et al. Granulocyte colony-stimulating factor and neutrophils—forgotten mediators of inflammatory disease. Nat Clin Pract Rheumatol 2006; 2: 500510.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17. Winkler IG, Lévesque JP. Mechanisms of hematopoietic stem cell mobilization: when innate immunity assails the cells that make blood and bone. Exp Hematol 2006; 34: 9961009.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18. Jädersten M, Malcovati L, Dybedal I, et al. Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome. J Clin Oncol 2008; 26: 36073613.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19. Gotlib J, Lavori P, Quesada S, et al. A phase II intra-patient dose-escalation trial of weight-based darbepoetin alfa with or without granulocyte-colony stimulating factor in myelodysplastic syndromes. Am J Hematol 2009; 84: 1520.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20. Nishida M, Fujimoto S, Toiyama K, et al. Effect of hematopoietic cytokines on renal function in cisplatin-induced ARF in mice. Biochem Biophys Res Commun 2004; 324: 341347.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21. Iwasaki M, Adachi Y, Minamino K, et al. Mobilization of bone marrow cells by G-CSF rescues mice from cisplatin-induced renal failure, and M-CSF enhances the effects of G-CSF. J Am Soc Nephrol 2005; 16: 658666.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22. Akihama S, Sato K, Satoh S, et al. Bone marrow-derived cells mobilized by granulocyte-colony stimulating factor facilitate vascular regeneration in mouse kidney after ischemia/reperfusion injury. Tohoku J Exp Med 2007; 213: 341349.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 23. Lin F, Cordes K, Li L, et al. Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 2003; 14: 11881199.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 24. Duffield JS, Park KM, Hsiao LL, et al. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 2005; 115: 17431755.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25. Dekel B, Shezen E, Even-Tov-Friedman S, et al. Transplantation of human hematopoietic stem cells into ischemic and growing kidneys suggests a role in vasculogenesis but not tubulogenesis. Stem Cells 2006; 24: 11851193.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26. Liu M, Chien CC, Burne-Taney M, et al. A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity. J Am Soc Nephrol 2006; 17: 765774.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 27. Watson AD, Lefebvre HP, Concordet D, et al. Plasma exogenous creatinine clearance test in dogs: comparison with other methods and proposed limited sampling strategy. J Vet Intern Med 2002; 16: 2233.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 28. Stokman G, Leemans JC, Claessen N, et al. Hematopoietic stem cell mobilization therapy accelerates recovery of renal function independent of stem cell contribution. J Am Soc Nephrol 2005; 16: 16841692.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 29. Ohki Y, Heissig B, Sato Y, et al. Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. FASEB J 2005; 19: 20052007.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30. Goldberg R, Dennen P. Long-term outcomes of acute kidney injury. Adv Chronic Kidney Dis 2008; 15: 297307.

  • 31. Eddy A. Role of cellular infiltrates in response to proteinuria. Am J Kidney Dis 2001; 37: S25S29.

  • 32. Ninichuk V, Gross O, Segerer S, et al. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int 2006; 70: 121129.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 33. Semedo P, Correa-Costa M, Antonio Cenedeze M, et al. Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model. Stem Cells 2009; 27: 30633073.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 34. Tögel F, Cohen A, Zhang P, et al. Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev 2009; 18: 475485.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 35. Asanuma H, Vanderbrink BA, Campbell MT, et al. Arterially delivered mesenchymal stem cells prevent obstruction-induced renal fibrosis. J Surg Res 2011; 168: e51e59.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 36. Fang TC, Alison MR, Cook HT. Proliferation of bone marrow-derived cells contributes to regeneration after folic acid-induced acute tubular injury. J Am Soc Nephrol 2005; 16: 17231732.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 37. Fujii K, Ishimaru F, Kozuka T, et al. Elevation of serum hepatocyte growth factor during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization. Br J Haematol 2004; 124: 190194.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 38. Li Y, Wu J, Shou Z, et al. Pretreatment with granulocyte colony-stimulating factor attenuated renal ischaemia and reperfusion injury via activation of PI3/Akt signal pathway. Nephrology (Carlton) 2008; 13: 508516.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 39. Nishida M, Hamaoka K. How does G-CSF act on the kidney during acute tubular injury? Nephron Exp Nephrol 2006; 104: e123e128.

  • 40. Steindler DA. Stem cells, regenerative medicine, and animal models of disease. ILAR J 2007; 48: 323338.

  • 41. Gandolfi F, Vanelli A, Pennarossa G, et al. Large animal models for cardiac stem cell therapies. Theriogenology 2011; 75: 14161425.

    • Crossref
    • Search Google Scholar
    • Export Citation

Advertisement